Loading...
156 Asia Chronic Disorder Drugs Reports
Region Covered: Asia
Study Period: 2019 - 2029
Countries Covered: China, Japan, India, Australia, South Korea
Major Players: Merck & Co. Inc., Bayer AG, Amgen Inc, AstraZeneca, Johnson & Johnson Services, Inc.
Region Covered: Asia
Study Period: 2019 - 2029
Countries Covered: China, Japan, India, Australia, South Korea
Major Players: AbbVie Inc., Pfizer Inc., Teva Pharmaceutical, Sun Pharmaceutical Industries Ltd, Novartis AG
Region Covered: Asia
Study Period: 2018 - 2029
Countries Covered: Australia, China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, Thailand, Vietnam
Major Players: Astrazeneca, Boehringer Ingelheim, Novo Nordisk A/S, Eli Lilly and Company, Sanofi Aventis
Country Covered: Japan
Study Period: 2018 - 2029
Major Players: Takeda, AstraZeneca, Boehringer Ingelheim, Novo Nordisk A/S, Sanofi Aventis
Country Covered: Oman
Study Period: 2018 - 2029
Major Players: AstraZeneca, Boehringer Ingelheim, Novo Nordisk A/S, Sanofi Aventis, Eli Lilly and Company
Country Covered: Indonesia
Study Period: 2019 - 2029
Major Players: Eli Lilly, Boehringer Ingelheim, Sanofi, Novo Nordisk, AstraZeneca
Country Covered: South Korea
Study Period: 2021- 2029
Major Players: AstraZeneca, Boehringer Ingelheim, Eli Lilly and Company, Novo Nordisk A/S, Sanofi Aventis
Country Covered: Thailand
Study Period: 2019 - 2029
Major Players: Eli Lilly, Boehringer Ingelheim, Astrazeneca, Sanofi, NovoNordisk
Country Covered: Philippines
Study Period: 2019 - 2029
Major Players: Eli Lilly, Boehringer Ingelheim, Astrazeneca, Sanofi, NovoNordisk
Country Covered: Malaysia
Study Period: 2019 - 2029
Major Players: Eli Lilly, Boehringer Ingelheim, Astrazeneca, Sanofi, NovoNordisk
Country Covered: Vietnam
Study Period: 2018 - 2029
Major Players: Eli Lilly, Boehringer Ingelheim, Astrazeneca, Sanofi, NovoNordisk
Country Covered: India
Study Period: 2019 - 2029
Major Players: Eli Lilly, Boehringer Ingelheim, Astrazeneca, Sanofi, NovoNordisk
Country Covered: Australia
Study Period: 2018 - 2029
Major Players: Eli Lilly, Boehringer Ingelheim, Astrazeneca, Sanofi, NovoNordisk
Country Covered: China
Study Period: 2018 - 2029
Major Players: Eli Lilly, Boehringer Ingelheim, Astrazeneca, Sanofi, Novo Nordisk
Country Covered: New Zealand
Study Period: 2019 - 2029
Major Players: Sanofi, Eli Lily, Novo Nordisk, Boehringer Ingelheim, Astrazeneca
Country Covered: Japan
Study Period: 2019 - 2029
Major Players: Sanofi, Eli Lilly, Astrazeneca, Janseen, Astellas
Country Covered: India
Study Period: 2019 - 2029
Major Players: Sanofi, Eli Lilly, Astellas, Janseen, Astrazeneca
Country Covered: New Zealand
Study Period: 2019 - 2029
Major Players: Sanofi, Eli Lilly, Astellas, Astrazeneca, Janseen
Region Covered: Asia
Study Period: 2019 - 2029
Countries Covered: Japan, South Korea, China, India, Australia, Vietnam, Malaysia, Indonesia, Philippines, Thailand
Major Players: Sanofi, Eli Lily, Astellas, Astrazeneca, Janssen
Country Covered: Malaysia
Study Period: 2019 - 2029
Major Players: Astrazeneca, Astellas, Janssen, Eli Lilly, Sanofi
Region Covered: Asia
Study Period: 2021 - 2029
Countries Covered: United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Korea, South Africa, Brazil, Argentina
Major Players: Philips, Colgate, DMG Dental, VOCO GmbH, Dentsply Sirona
Region Covered: Asia
Study Period: 2019-2029
Countries Covered: United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Korea, South Africa, Brazil, Argentina
Major Players: Abbvie Inc. , Bayer AG, Cipla Inc, Abbott, Takeda Pharmaceutical Company Limited
Region Covered: Asia
Study Period: 2019 - 2029
Countries Covered: United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Korea, South Africa, Brazil, Argentina
Major Players: Evoke Pharma, AstraZeneca, Cadila Pharmaceuticals, Neurogastrx, Inc., AbbVie Inc. ( Allergan Plc)
Region Covered: Asia
Study Period: 2019 - 2029
Countries Covered: United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Korea, South Africa, Brazil, Argentina
Major Players: Amgen Inc., AstraZeneca PLC, Hoffmann-La Roche AG, GlaxoSmithKline PLC, Eli Lilly and Company
Region Covered: Asia
Study Period: 2019 - 2029
Countries Covered: United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Korea, South Africa, Brazil, Argentina
Major Players: Abbott Laboratories, Gilead Sciences, Novartis AG, Sanofi, Astellas Pharma Inc.
Region Covered: Asia
Study Period: 2019 - 2029
Countries Covered: United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Korea, South Africa, Brazil, Argentina
Major Players: Abbott Laboratories, Axogen Corporation, Medtronic, Boston Scientific Corporation, Integra LifeSciences Corporation
Region Covered: Asia
Study Period: 2019 - 2029
Countries Covered: United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Korea, South Africa, Brazil, Argentina
Major Players: Abbott Laboratories Inc, Eli Lilly and Company, Teva Pharmaceutical Industries Ltd, Endo International, Ferring Pharmaceuticals
Region Covered: Asia
Study Period: 2019 - 2029
Countries Covered: United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Korea, South Africa, Brazil, Argentina
Major Players: Abbott Laboratories, GlaxoSmithKline PLC, Johnson & Johnson Health Care Systems Inc., Novartis AG, UCB S.A.
Region Covered: Asia
Study Period: 2021 - 2029
Countries Covered: United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Africa, Brazil, Argentina
Major Players: Pfizer Inc., Abbvie Inc., Bristol Myers Squibb, Regeneron Pharmaceuticals, Inc., Evelo Biosciences, Inc.
Region Covered: Asia
Study Period: 2019 - 2029
Countries Covered: United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Korea, South Africa, Brazil, Argentina
Major Players: Takeda Pharmaceutical Company Limited , Bristol-Myers Squibb, LUPIN, Accord Healthcare, Otsuka America Pharmaceutical, Inc.
Filter Reports
By Countries